Trial NCT03770455

View at ClinicalTrials.gov 
Org. Study IDs: 2018-1236

Last trial update was posted on 2022-05-03

MeSH Interventions

Avelumab

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Metastatic Castration-resistant Prostate Cancer

Stopping Reasons

Early signs of progression and learned experience that the assumed time period between psa progression and radiographic progression was shorter than expected

Limitations And Caveats

Study did not reach target number of participants needed to reach target power for statistically reliable results due to poor recruitment during COIVD pandemic and early termination of study. Study closed early due to safety concerns regarding rapid clinical progression of several participants.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID